| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 224,198 | 216,981 | 299,252 | 277,282 | | Cost of Revenue | 183,678 | 180,099 | 241,724 | 228,740 | | | Gross Profit | 40,520 | 36,882 | 57,528 | 48,542 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 12,221 | 12,633 | 15,289 | 16,537 | | Non Recurring | 1,616 | 607,954 | 31,033 | 4,620 | | Others | 12,661 | 13,133 | 13,536 | 13,404 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 14,022 | (596,838) | (2,330) | 13,981 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 7,489 | 1,844 | 1,945 | 1,475 | | Earnings Before Interest And Taxes | 21,511 | (594,994) | (385) | 15,456 | | Interest Expense | 5,445 | 5,335 | 3,282 | 2,759 | | Income Before Tax | 16,066 | (600,329) | (3,667) | 12,697 | | Income Tax Expense | 6,044 | (84,530) | 7,043 | 7,556 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 10,022 | (515,799) | (10,710) | 5,141 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 10,022 | (515,799) | (10,710) | 5,141 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $10,022 | ($515,799) | ($10,710) | $5,141 |
|
0.63% Nasdaq 
0.03%
Income Statement
